| scholarly article | Q13442814 |
| P50 | author | Florian Herse | Q47804678 |
| Kedra Wallace | Q56256861 | ||
| Gerd Wallukat | Q63288594 | ||
| Ralf Dechend | Q63812628 | ||
| P2093 | author name string | Jeremy Scott | |
| Babbette LaMarca | |||
| Denise C Cornelius | |||
| Lorena M Amaral | |||
| Alexia J Thomas | |||
| Nathan Campbell | |||
| P2860 | cites work | AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 |
| Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia | Q82705098 | ||
| Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia | Q83391804 | ||
| The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia | Q83523001 | ||
| Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension | Q83799951 | ||
| A leading role for the immune system in the pathophysiology of preeclampsia | Q27003069 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Recent insights into the pathophysiology of preeclampsia | Q34404445 | ||
| Recent Insights into the pathogenesis of pre-eclampsia | Q34682287 | ||
| CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy | Q35130793 | ||
| Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction | Q35576417 | ||
| IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? | Q35581520 | ||
| Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats | Q35994304 | ||
| Activating auto-antibodies against the AT1 receptor in preeclampsia | Q36010629 | ||
| The Th1:th2 dichotomy of pregnancy and preterm labour. | Q36037674 | ||
| IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy | Q36178540 | ||
| Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia | Q36380482 | ||
| The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
| The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia | Q37088970 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats | Q37449704 | ||
| Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy | Q37507162 | ||
| Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy | Q37747554 | ||
| Deciphering the role of Th17 cells in human disease | Q37940695 | ||
| Th17 and regulatory T cells in women with recurrent pregnancy loss | Q37989545 | ||
| Interleukin-6 in pregnancy and gestational disorders | Q38028200 | ||
| Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia | Q46332630 | ||
| Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. | Q51470693 | ||
| Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of preeclampsia | Q61845360 | ||
| P433 | issue | 6 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| pathophysiology | Q1135939 | ||
| P304 | page(s) | R1192-R1199 | |
| P577 | publication date | 2016-10-26 | |
| P1433 | published in | American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | Q2201819 |
| P1476 | title | Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy | |
| P478 | volume | 311 |
| Q64068024 | Chronic infusion of interleukin-17 promotes hypertension, activation of cytolytic natural killer cells, and vascular dysfunction in pregnant rats |
| Q89522650 | Dietary Protein: Mechanisms Influencing Hypertension and Renal Disease |
| Q91945249 | Identification of High-Risk Pregnancies in a Remote Setting Using Ambulatory Blood Pressure: The MINDI Cohort |
| Q49600503 | Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities |
| Q46300954 | Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia |
| Q47637232 | Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure |
| Q90628338 | Neurodevelopmental Outcomes of Prenatal Preeclampsia Exposure |
| Q88542480 | Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy |
| Q104137018 | Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction |
| Q57057008 | Regulatory T cells in embryo implantation and the immune response to pregnancy |
| Q47819556 | The placental bed vascular pathology revisited: a risk indicator for cardiovascular disease |
| Q64065212 | Therapeutic Potential of Regulatory T Cells in Preeclampsia-Opportunities and Challenges |
| Q54680135 | Uncovering novel roles for matrix metalloproteinases in preeclampsia. |
| Q47968875 | Undifferentiated connective tissue diseases and adverse pregnancy outcomes. An undervalued association? |
Search more.